Navigation Links
Study Finds Proof of Acupuncture Success
Date:12/6/2012

DUBLIN, December 6, 2012 /PRNewswire/ --

Acupuncture has been long been lauded by many who are convinced of its positive effect on pain. It appears that such claims can be backed up by a certain amount of technical research after a team at the University of Southampton conducted a study into the role acupuncture plays in the field of pain management.

Millions of people around the world suffer from chronic pain and pain management teams have been working on all sorts of strategies to help them deal with their own individual complaints. The strategies vary and take into account all sorts of methods, from drug therapy to physical therapy.

Acupuncture is another technique that many sufferers of chronic pain swear by and the team in Southampton, led by Professor George Lewith, have looked at a host of cases of back pain, neck pain and joint pain in a bid to assess the efficacy of this popular alternative treatment.

The results of the study made positive reading for clinics such as Fitzwilliam Health Clinic. The patients who were treated using acupuncture to supplement other techniques tended to find that their pain was eased alleviated more effectively than that of patients who received no acupuncture alongside their usual pain management regimes.

Fitzwilliam Health Clinic has been providing acupuncture alongside other forms of chiropractic, massage and physical therapy treatments for years and it has built up an excellent reputation for dealing with pain.

Patients already visit http://www.fitzwilliamhealth.ie to seek advice and treatment for complaints of all kinds and acupuncture is one of the most sought after therapies available at the clinic. It is expected that the site will see even more traffic in the future as acupuncture receives more attention in light of recent studies into its efficacy as a treatment for chronic pain.

One of the drawbacks for acupuncture tends to be a widespread sense of scepticism about whether it has the desired effect. However, Professor Lewith, who took charge of the study at the University of Southampton, stated:

"Acupuncture is a treatment that is not readily recommended by clinicians but these results will confirm that the effects of acupuncture are beneficial."

Only time will tell whether the technique will earn more champions in the future, but positive results are always a good sign in the field of medical trials.

As well as offering the latest acupuncture treatment Fitzwilliam Health Care are able to offer many forms of Physical Therapy, including Sports Massage and also Fertility Treatment.

Amanda Hughes, Tel No: +353(1)661-8949, email address: info@fitzwilliamhealth.ie


'/>"/>
SOURCE Fitzwilliam Health Clinic
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Positive Clinical Study Results for BSPs HyperQ Technology
2. 15-Minute Data From Phase 3 Study of Avanafil Featured as a Late Breaking Abstract at SMSNA Annual Meeting
3. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
4. Marshall study shows nanoparticles used as additives in diesel fuels can travel from lungs to liver
5. Clionsky Neuro Systems (CNS-Neuro) Announces Publication of Study Finding Elderly Patients Unable to Recognize Their Memory Loss
6. Convergence Pharmaceuticals Initiates Phase I Multiple Ascending Dose Study for CNV2197944
7. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
8. Singapore scientists lead human embryonic stem cell study
9. GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly
10. Nutra Pharma Announces Publication of a New Mechanism Study of Alpha-Cobratoxin in the Treatment of Pain
11. Metabolex Announces Positive Results From its Clinical Study of Arhalofenate in Combination With Febuxostat
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... Amarantus BioScience Holdings, Inc. ... developing products for Regenerative Medicine, Neurology and Orphan Diseases, ... (RPDD) from the US Food and Drug Administration (FDA) ... previously granted orphan drug designation (ODD) by the US ... Holdings, Inc. (OTCQB: AMBS), a biotechnology ...
(Date:2/4/2016)... New FDA action date of July 22, 2016   ... 22, 2016   --> - New FDA ... - Lifitegrast has the potential to be the only product approved ... and symptoms of dry eye disease in adults --> - ... the U.S. in the past decade indicated for the treatment of signs and ...
(Date:2/4/2016)... Church, VA (PRWEB) , ... ... ... first-year cybersecurity conference presented by Bloomsburg University’s Digital Forensics Club, takes place ... PA. The two-day event features 20+ speakers and activities such as workshops ...
(Date:2/4/2016)... MENLO PARK, Calif. , Feb. 4, 2016 ... the "Company"), a biopharmaceutical company focused on the development and ... present at the 18 th Annual BIO CEO ... 10:00 a.m. EST in New York, NY ... CEO, will provide an update on the ongoing clinical trial ...
Breaking Biology Technology:
(Date:1/28/2016)... SYNA ), a leading developer of human interface solutions, today ... --> --> Net revenue ... to the comparable quarter last year to $470.5 million. Net income ... $0.93 per diluted share. --> ... 2016 grew 9 percent over the prior year period to $60.3 ...
(Date:1/22/2016)... January 22, 2016 ... addition of the  "Global Behavioral Biometric ... --> http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has ... Behavioral Biometric Market 2016-2020"  report to ... and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ) has announced ...
(Date:1/20/2016)... , Jan. 20, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... significant achievements are the result of the company,s laser ... iMedNet eClinical , it,s comprehensive, easy-to-use and highly ... --> Key MedNet growth achievements in 2015 ...
Breaking Biology News(10 mins):